Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study.
about
Variation in oral calcitriol response in patients with stages 3-4 CKD.Estimation of the stability of parathyroid hormone when stored at -80 degrees C for a long period.Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals.Primary hyperparathyroidism: an overview.Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients.Prevalence of CKD-MBD in pre-dialysis patients using biochemical markers in Enugu, South-East Nigeria.Interpretation of serum parathyroid hormone concentrations in dialysis patients: what do the KDIGO guidelines change for the clinical laboratory?Parathyroid hormone measurement in chronic kidney disease--an evolving issue for the nephrologist and the clinical laboratorist: minireview.Pharmacological Management of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease.Comparison of Intact PTH and Bio-Intact PTH Assays Among Non-Dialysis Dependent Chronic Kidney Disease Patients.Comparing the values of intact parathormone and 1- 84 PTH to predict hyperparathyroidism in hemodialysis patients.Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients--results of the Austrian cohort of the ECHO study.Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study.Serum bone resorption markers after parathyroidectomy for renal hyperparathyroidism: correlation analyses for the cross-linked N-telopeptide of collagen I and tartrate-resistant acid phosphatase
P2860
Q30513471-EE410339-7F5A-463E-8F21-7A49BA69711FQ33560470-26F0E463-8957-447D-A231-F10D82BB6698Q33862710-D71B657A-4DA7-4942-9486-62F2D59F0712Q35071213-2BE226D1-2594-4CE2-8897-186CA6891569Q35219236-1EEBD72F-3AA3-4478-A9F5-10A3351AED29Q36612883-DE5FF6E8-8E56-417B-BF38-0165771968C0Q37713739-3720B5B0-555E-4875-9C7D-2C38C8118B79Q37972396-9B925F6C-A407-41B5-8AC4-75FA3216DDEFQ38824573-7764968E-511D-4982-B7AE-F34C079064A0Q40148419-2BF48A8D-272E-4998-A8E9-6A36FE49534AQ42361935-FB546F92-7669-44D3-9F70-BB03CD5EBF3FQ44186583-2A8DE627-D5DA-47CC-A698-74362FFE93D2Q45160013-5C468BF5-DB9A-4F00-999B-6F5DC2A523D8Q58914797-EE7244D1-3FAA-4C27-9555-673F1A02701E
P2860
Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Third-generation parathyroid h ...... is patients: the CHOICE study.
@en
Third-generation parathyroid h ...... is patients: the CHOICE study.
@nl
type
label
Third-generation parathyroid h ...... is patients: the CHOICE study.
@en
Third-generation parathyroid h ...... is patients: the CHOICE study.
@nl
prefLabel
Third-generation parathyroid h ...... is patients: the CHOICE study.
@en
Third-generation parathyroid h ...... is patients: the CHOICE study.
@nl
P2093
P356
P1476
Third-generation parathyroid h ...... is patients: the CHOICE study.
@en
P2093
Joseph A Eustace
Laura C Plantinga
Michal L Melamed
Nancy E Fink
Neil R Powe
Rulan S Parekh
Tom Cantor
P304
P356
10.1093/NDT/GFM849
P407
P577
2007-12-08T00:00:00Z